Psychopathological disorders in chronic cerebral ischemia: possibilities of prevention

Anxiety, depression, somatoform disorders, nosogenic reactions, adjustment disorders, neurasthenia, somatogenic asthenia in patient with chronic cerebral ischemia (dyscirculatory encephalopathy, cerebrovascular disease) (CCI) are very important for the level of social functioning and adaptation. Ear...

Full description

Saved in:
Bibliographic Details
Main Authors: O. V. Kotova, N. L. Zuykova, A. V. Palin, V. I. Frolova, E. V. Gushanskaya, I. V. Salyntsev, V. E. Medvedev
Format: Article
Language:Russian
Published: Open Systems Publication 2021-07-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/747
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248533994012672
author O. V. Kotova
N. L. Zuykova
A. V. Palin
V. I. Frolova
E. V. Gushanskaya
I. V. Salyntsev
V. E. Medvedev
author_facet O. V. Kotova
N. L. Zuykova
A. V. Palin
V. I. Frolova
E. V. Gushanskaya
I. V. Salyntsev
V. E. Medvedev
author_sort O. V. Kotova
collection DOAJ
description Anxiety, depression, somatoform disorders, nosogenic reactions, adjustment disorders, neurasthenia, somatogenic asthenia in patient with chronic cerebral ischemia (dyscirculatory encephalopathy, cerebrovascular disease) (CCI) are very important for the level of social functioning and adaptation. Early initiation of CCI therapy is an important task in preventing the progression not only of cerebrovascular pathology, but also a wide range of comorbid psychopathological disorders. Treatment of patients with CCI requires an individual approach taking into account pathogenetic factors and severity of both cognitive and psychopathological disorders. It should involve a wide range of drugs, including neuroprotectors. For this purpose the neuroprotective agents ethylmethyloxypyridine succinate and citicoline can be used for independent or combined use. Patients with various forms of CCI noticed subjective improvement during treatment which includes decreasing fatigability and general weakness, reduction of symptoms of psychic and somatic anxiety, fatigability, emotional lability, increasing activity and motivation, improvement of memory, attention, ability to concentrate that positively influences their professional activity.
format Article
id doaj-art-08c83c6aa31343239ebd6a87d13ab265
institution Kabale University
issn 1560-5175
2687-1181
language Russian
publishDate 2021-07-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-08c83c6aa31343239ebd6a87d13ab2652025-08-20T03:57:51ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812021-07-0105222610.51793/OS.2021.15.98.005746Psychopathological disorders in chronic cerebral ischemia: possibilities of preventionO. V. Kotova0N. L. Zuykova1A. V. Palin2V. I. Frolova3E. V. Gushanskaya4I. V. Salyntsev5V. E. Medvedev6Peoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University); Psychiatric Clinically Hospital named after P. B. Gannushkin № 4Peoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University); Psychiatric Clinically Hospital № 13Peoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University); Clinical Hospital No. 1 UDP of the Russian FederationAnxiety, depression, somatoform disorders, nosogenic reactions, adjustment disorders, neurasthenia, somatogenic asthenia in patient with chronic cerebral ischemia (dyscirculatory encephalopathy, cerebrovascular disease) (CCI) are very important for the level of social functioning and adaptation. Early initiation of CCI therapy is an important task in preventing the progression not only of cerebrovascular pathology, but also a wide range of comorbid psychopathological disorders. Treatment of patients with CCI requires an individual approach taking into account pathogenetic factors and severity of both cognitive and psychopathological disorders. It should involve a wide range of drugs, including neuroprotectors. For this purpose the neuroprotective agents ethylmethyloxypyridine succinate and citicoline can be used for independent or combined use. Patients with various forms of CCI noticed subjective improvement during treatment which includes decreasing fatigability and general weakness, reduction of symptoms of psychic and somatic anxiety, fatigability, emotional lability, increasing activity and motivation, improvement of memory, attention, ability to concentrate that positively influences their professional activity.https://journal.lvrach.ru/jour/article/view/747chronic cerebral ischemiadyscirculatory encephalopathysmall vessel diseasemental disordersneuroprotection
spellingShingle O. V. Kotova
N. L. Zuykova
A. V. Palin
V. I. Frolova
E. V. Gushanskaya
I. V. Salyntsev
V. E. Medvedev
Psychopathological disorders in chronic cerebral ischemia: possibilities of prevention
Лечащий Врач
chronic cerebral ischemia
dyscirculatory encephalopathy
small vessel disease
mental disorders
neuroprotection
title Psychopathological disorders in chronic cerebral ischemia: possibilities of prevention
title_full Psychopathological disorders in chronic cerebral ischemia: possibilities of prevention
title_fullStr Psychopathological disorders in chronic cerebral ischemia: possibilities of prevention
title_full_unstemmed Psychopathological disorders in chronic cerebral ischemia: possibilities of prevention
title_short Psychopathological disorders in chronic cerebral ischemia: possibilities of prevention
title_sort psychopathological disorders in chronic cerebral ischemia possibilities of prevention
topic chronic cerebral ischemia
dyscirculatory encephalopathy
small vessel disease
mental disorders
neuroprotection
url https://journal.lvrach.ru/jour/article/view/747
work_keys_str_mv AT ovkotova psychopathologicaldisordersinchroniccerebralischemiapossibilitiesofprevention
AT nlzuykova psychopathologicaldisordersinchroniccerebralischemiapossibilitiesofprevention
AT avpalin psychopathologicaldisordersinchroniccerebralischemiapossibilitiesofprevention
AT vifrolova psychopathologicaldisordersinchroniccerebralischemiapossibilitiesofprevention
AT evgushanskaya psychopathologicaldisordersinchroniccerebralischemiapossibilitiesofprevention
AT ivsalyntsev psychopathologicaldisordersinchroniccerebralischemiapossibilitiesofprevention
AT vemedvedev psychopathologicaldisordersinchroniccerebralischemiapossibilitiesofprevention